ArticleFrontiers in pharmacology2026

Dexmedetomidine attenuates Alzheimer's pathogenesis by targeting the ROS-mediated XIAP-MDM2-p53 signaling axis.

Weiwei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.